HMGB3 as a transcription factor, binds to the promoter region of hTERT andactivates transcriptionally hTERT expression, which leads to radiation resistance of cervical cancer.Targeting HMGB3 /hTERT signaling axis may provide an important strategy in cervical cancer treatment. Here, HMGB3 is linked to cervical carcinoma.